xDbio, a BMV MEDTECH company, exhibited at Medlab Middle East 2024, held February 5–8, 2024 at the Dubai World Trade Centre. At the show, xDbio presented a full range of in-vitro diagnostic and point-of-care solutions — hematology, clinical chemistry, immunoassay, blood-gas and electrolyte analysis, PCR and POCT — offering coordinated solutions for large, medium and small laboratories to a global audience.
Medlab Middle East 2024
Medlab Middle East is one of the world’s largest laboratory and diagnostics exhibitions, bringing together manufacturers, laboratory professionals, distributors and healthcare buyers from the Middle East, Africa, Asia and beyond. The 2024 edition opened at the Dubai World Trade Centre on February 5 and ran across four days of exhibitions, conferences and business meetings.
Event facts
- Event: Medlab Middle East 2024
- Dates: February 5–8, 2024
- Venue: Dubai World Trade Centre, Dubai, United Arab Emirates
- On display: IVD and POCT diagnostic solutions
Hematology: from routine CBC to advanced analysis
xDbio showcased its tiered hematology line, allowing distributors and laboratories to match systems to workload — the XD113 3-part and XD115 5-part for routine and mid-volume testing, the XD116 6-part and high-performance XD118 5-part for larger laboratories, and the XD110 for AI-assisted cell morphology and advanced review.
Chemistry and immunoassay
For routine and specialized chemistry, xDbio presented automated biochemistry systems alongside immunoassay platforms, supporting hospitals and laboratories with high-throughput, walkaway workflows and a broad test menu covering routine screening and specialized markers.
Blood gas, electrolytes and molecular diagnostics
The critical-care display included blood-gas and electrolyte analyzers for rapid results in emergency, ICU and point-of-care settings, together with PCR platforms for molecular diagnostics, giving partners a complete diagnostic offer from bedside testing to the central laboratory.
POCT for bedside and primary care
xDbio also demonstrated its POCT portfolio, designed around simple operation, fast turnaround and compact formats suited to primary healthcare facilities, small-to-medium laboratories and bedside testing, with single-use consumables that simplify workflow in low-volume settings.
Global exchange and partnerships
Throughout the show, the xDbio team met laboratory directors and prospective distributors, demonstrated live workflows and discussed OEM/ODM and white-label cooperation. The same diagnostic modalities are available in a dedicated veterinary line, enabling partners to serve both human healthcare and animal-diagnostic markets. xDbio thanked visitors and looked ahead to continued collaboration across the Middle East, Africa and worldwide.
Frequently asked questions
Did xDbio exhibit at Medlab Middle East 2024?
Yes. xDbio took part in Medlab Middle East 2024, February 5–8, at the Dubai World Trade Centre.
What did xDbio present at Medlab 2024?
Hematology, clinical chemistry, immunoassay, blood-gas and electrolyte, PCR and POCT solutions for laboratories of all sizes.
Which hematology systems were shown?
The XD110, XD113, XD115, XD116 and XD118, covering routine CBC through to AI-assisted morphology.
Where is Medlab Middle East held?
At the Dubai World Trade Centre in the United Arab Emirates; the 2024 edition ran February 5–8.
Does xDbio offer OEM or white-label products?
Yes, OEM/ODM and white-label options are available through BMV MEDTECH.
Is xDbio part of BMV MEDTECH?
Yes, xDbio is a BMV MEDTECH company.